Clinical Research Report Synopsis



Save, fill-In The Blanks, Print, Done!

Click on image to zoom / Click button below to see more images


Adobe Acrobat (.pdf)

  • This Document Has Been Certified by a Professional
  • 100% customizable
  • This is a digital download (67.45 kB)
  • Language: English
  • We recommend downloading this file onto your computer.


  
ABT template rating: 7

Malware- and virusfree. Scanned by: Norton safe website

How to draft a Clinical Research? An easy way to start your Clinical Research is to download this Clinical Research Report Synopsis template now!

Every day brings new projects, emails, documents, and task lists, and often it is not that different from the work you have done before. Many of our day-to-day tasks are similar to something we have done before. Don't reinvent the wheel every time you start to work on something new!

Instead, we provide this standardized Clinical Research template with text and formatting as a starting point to help professionalize the way you are working. Our private, business and legal document templates are regularly screened by professionals. If time or quality is of the essence, this ready-made template can help you to save time and to focus on the topics that really matter!

Using this document template guarantees you will save time, cost and efforts! It comes in Microsoft Office format, is ready to be tailored to your personal needs. Completing your document has never been easier!

Download this Clinical Research template now for your own benefit!

Possible pregnancy or lactation Treatment Form - dosing route matching tablets - oral Dose 4 mg 8 mg 12 mg Galantamine Dosage 2 tablets daily (bid) with meals, at 8 AM and 6 PM Duration of treatment 6 months Duration of trial 6 months Disallowed medication drugs for treating dementia (nootropic or cholinomimetic agents, estrogens, chronic NSAIDs, ≥30 IU vitamin E daily, deprenyl) sedatives given more than twice weekly Item 8: Clinical/Statistical Data Page 12 (galantamine) Tablets New Drug Application 21-169 Janssen Research Foundation JRF Clinical Research Report - GAL-USA-3 Assessments Initial (Final visit of GAL-USA-1) 13 Weeks 1,2,3 M1 M2 M3 M 4,5 Final M6 Efficacy = Alzheimer’s Disease Assessment Scale CIBIC=Clinician’s Interview-based Impression of Change DAD=Disability Assessment in Dementia M=Month Statistical Methods Variable Change at Month 6 in ADAS-cog/11, cog/13, -cog/10, -cog/mem DAD, PGWB CIBIC-plus Adverse events Change in vital signs, body weight, ECG Laboratory results Item 8: Clinical/Statistical Data Method ANOVA, paired t-test, Fisher’s LSD ANCOVA (subgroup only) Cochran-Mantel-Haenszel, Van Elteren test Number/ with AE ANOVA, paired t-test, Fisher’s LSD Tabulations of values outside normal and pathological limits Page 13 REMINYL (galantamine) Tablets New Drug Application Research Foundation JRF Clinical Research Report - GAL-USA-3 14 Main features of the patient sample and summary of the results Baseline characteristics: patient disposition Number of patients treated (M/F) Age: yrs (mean±SE) Premature discontinuations - reason • adverse event • noncompliant • other Total of discontinuations PL




DISCLAIMER
Nothing on this site shall be considered legal advice and no attorney-client relationship is established.


Leave a Reply. If you have any questions or remarks, feel free to post them below.


default user img

People are best convinced by things they themselves discover. | Ben Franklin